← Leaderboards
Jun Zhu
University Of South Carolina At Columbia
$7,249,782
Attributed
$13,299,567
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,299,567 · 7
By mechanism
R01$12,047,944 · 3
R21$821,063 · 2
R03$430,560 · 2
Top collaborators
- Chang-Guo Zhan10 shared
- Jay P Mclaughlin7 shared
- Corinne Elizabeth Augelli-Szafran6 shared
- Michael Shtutman2 shared
- Michael D Wyatt2 shared
Others in their field
Top investigators on “Hiv-1”
- Barton F Haynes · Duke University$476,288,740
- Lawrence Corey · Fred Hutchinson Cancer Center$445,419,385
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$294,186,693
- Constance Ann Benson · University Of California, San Diego$272,046,180
- Peter B. Gilbert · Fred Hutchinson Cancer Center$173,010,936
- Dan H. Barouch · Fred Hutchinson Cancer Center$166,542,502
Research focus
Hiv-1BrainMediatingCocaineDopamineInfectionFunctional DisorderDrug Of AbuseDopamine TransporterBinding SitesPlayAntiretroviral TherapyUptakePublishingBehavioralSeveritiesNeurocognitive DeficitIncidenceBindingCellsMutantImpairmentAttenuatedIn Vitro
Grant awards (29)
Molecular mechanisms: Dysregulation of monoamine transporters by HIV-1Tat and cocaine$728,575
R01 · FY2025 · DA · contact PI
Effects of HIV-1 Tat protein and methamphetamine on VMAT2-mediated dopamine transmission in the context of neuroHIV and drug abuse$642,302
R01 · FY2025 · DA · contact PI
Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS$927,795
R01 · FY2024 · DA
Molecular mechanisms: Dysregulation of monoamine transporters by HIV-1 Tat and cocaine$696,079
R01 · FY2024 · DA · contact PI
Effects of HIV-1 Tat protein and methamphetamine on VMAT2-mediated dopamine transmission in the context of neuroHIV and drug abuse$642,302
R01 · FY2024 · DA · contact PI
Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS$791,611
R01 · FY2023 · DA
Effects of HIV-1 Tat protein and methamphetamine on VMAT2-mediated dopamine transmission in the context of neuroHIV and drug abuse$654,552
R01 · FY2023 · DA · contact PI
Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS$148,255
R01 · FY2023 · DA
Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS$784,203
R01 · FY2022 · DA
Molecular mechanisms: Dysregulation of monoamine transporters by HIV-1 Tat and cocaine$515,165
R01 · FY2022 · DA · contact PI
Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS$794,235
R01 · FY2021 · DA
Molecular mechanisms: Dysregulation of monoamine transporters by HIV-1 Tat and cocaine$515,554
R01 · FY2021 · DA · contact PI
Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS$805,690
R01 · FY2020 · DA
Molecular mechanisms: Dysregulation of monoamine transporters by HIV-1 Tat and cocaine$515,165
R01 · FY2020 · DA · contact PI
Impact of Dead Box RNA Helicase 3 signaling on HIV-1 Tat- and cocaine-induced neurotoxicity$185,493
R21 · FY2020 · DA
Molecular mechanisms: Dysregulation of monoamine transporters by HIV-1 Tat and cocaine$515,554
R01 · FY2019 · DA · contact PI
Impact of Dead Box RNA Helicase 3 signaling on HIV-1 Tat- and cocaine-induced neurotoxicity$222,765
R21 · FY2019 · DA
Molecular mechanisms: Dysregulation of monoamine transporters by HIV-1 Tat and cocaine$537,119
R01 · FY2018 · DA · contact PI
Impact of HIV-1 Tat protein on cocaine-dopamine transporter interaction$366,597
R01 · FY2017 · DA · contact PI
Knock-in mouse model of dopamine transporter-Tat interaction underlying NeuroAIDS$183,910
R21 · FY2017 · DA · contact PI
Impact of HIV-1 Tat protein on cocaine-dopamine transporter interaction$362,798
R01 · FY2016 · DA · contact PI
Knock-in mouse model of dopamine transporter-Tat interaction underlying NeuroAIDS$228,895
R21 · FY2016 · DA · contact PI
Impact of HIV-1 Tat protein on cocaine-dopamine transporter interaction$360,839
R01 · FY2015 · DA · contact PI
Impact of HIV-1 Tat protein on cocaine-dopamine transporter interaction$366,215
R01 · FY2014 · DA · contact PI
Impact of HIV-1 Tat protein on cocaine-dopamine transporter interaction$377,339
R01 · FY2013 · DA · contact PI
Role of Dopamine Transporter: HIV-1 Tat Protein and Nicotine Sensitization$142,560
R03 · FY2010 · DA · contact PI
Role of DARPP-32: Individual Responsiveness to Nicotine$72,000
R03 · FY2010 · DA · contact PI
Role of Dopamine Transporter: HIV-1 Tat Protein and Nicotine Sensitization$144,000
R03 · FY2009 · DA · contact PI
Role of DARPP-32: Individual Responsiveness to Nicotine$72,000
R03 · FY2009 · DA · contact PI